Next Generation Cancer Diagnostics Report 2018 – Global Industry Analysis, Opportunities and Forecasts to 2025

“Next Generation Cancer Diagnostics”
This report covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies

This report studies the global Next Generation Cancer Diagnostics market, analyzes and researches the Next Generation Cancer Diagnostics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
Cepheid
Koninklijke Philips N.V
F. Hoffmann-La Roche Ltd
Qiagen
Novartis AG
Abbott
Thermo Fisher Scientific
Opko Health
Myriad Genetics
Agilent Technologies
GE Healthcare
PerkinElmer
Genomic Health
Illumina
Hologic
Almac Group
Janssen Global Services
Sysmex Corporation

Request a Sample Report @  https://www.wiseguyreports.com/sample-request/2985722-global-next-generation-cancer-diagnostics-market-size-status-and-forecast-2025

Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia

Market segment by Type, the product can be split into
Next Generation Sequencing
qPCR & Multiplexing
DNA Microarrays
Other

Market segment by Application, Next Generation Cancer Diagnostics can be split into
Hospitals
Clinics
Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

Global Next Generation Cancer Diagnostics Market Size, Status and Forecast 2025
1 Industry Overview of Next Generation Cancer Diagnostics
1.1 Next Generation Cancer Diagnostics Market Overview
1.1.1 Next Generation Cancer Diagnostics Product Scope
1.1.2 Market Status and Outlook
1.2 Global Next Generation Cancer Diagnostics Market Size and Analysis by Regions (2013-2018)
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Next Generation Cancer Diagnostics Market by Type
1.3.1 Next Generation Sequencing
1.3.2 qPCR & Multiplexing
1.3.3 DNA Microarrays
1.3.4 Other
1.4 Next Generation Cancer Diagnostics Market by End Users/Application
1.4.1 Hospitals
1.4.2 Clinics
1.4.3 Other

2 Global Next Generation Cancer Diagnostics Competition Analysis by Players
2.1 Next Generation Cancer Diagnostics Market Size (Value) by Players (2013-2018)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
3.1 Cepheid
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Next Generation Cancer Diagnostics Revenue (Million USD) (2013-2018)
3.1.5 Recent Developments
3.2 Koninklijke Philips N.V
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Next Generation Cancer Diagnostics Revenue (Million USD) (2013-2018)
3.2.5 Recent Developments
3.3 F. Hoffmann-La Roche Ltd
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Next Generation Cancer Diagnostics Revenue (Million USD) (2013-2018)
3.3.5 Recent Developments
3.4 Qiagen
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Next Generation Cancer Diagnostics Revenue (Million USD) (2013-2018)
3.4.5 Recent Developments
3.5 Novartis AG
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Next Generation Cancer Diagnostics Revenue (Million USD) (2013-2018)
3.5.5 Recent Developments
3.6 Abbott
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Next Generation Cancer Diagnostics Revenue (Million USD) (2013-2018)
3.6.5 Recent Developments
3.7 Thermo Fisher Scientific
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Next Generation Cancer Diagnostics Revenue (Million USD) (2013-2018)
3.7.5 Recent Developments
3.8 Opko Health
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Next Generation Cancer Diagnostics Revenue (Million USD) (2013-2018)
3.8.5 Recent Developments
3.9 Myriad Genetics
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Next Generation Cancer Diagnostics Revenue (Million USD) (2013-2018)
3.9.5 Recent Developments
3.10 Agilent Technologies
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Next Generation Cancer Diagnostics Revenue (Million USD) (2013-2018)
3.10.5 Recent Developments
3.11 GE Healthcare
3.12 PerkinElmer
3.13 Genomic Health
3.14 Illumina
3.15 Hologic
3.16 Almac Group
3.17 Janssen Global Services
3.18 Sysmex Corporation

4 Global Next Generation Cancer Diagnostics Market Size by Type and Application (2013-2018)
4.1 Global Next Generation Cancer Diagnostics Market Size by Type (2013-2018)
4.2 Global Next Generation Cancer Diagnostics Market Size by Application (2013-2018)
4.3 Potential Application of Next Generation Cancer Diagnostics in Future
4.4 Top Consumer/End Users of Next Generation Cancer Diagnostics

5 United States Next Generation Cancer Diagnostics Development Status and Outlook
5.1 United States Next Generation Cancer Diagnostics Market Size (2013-2018)
5.2 United States Next Generation Cancer Diagnostics Market Size and Market Share by Players (2013-2018)
5.3 United States Next Generation Cancer Diagnostics Market Size by Application (2013-2018)

……Continued

Access Complete Report @ https://www.wiseguyreports.com/reports/2985722-global-next-generation-cancer-diagnostics-market-size-status-and-forecast-2025

Media Contact
Company Name: Wiseguyreports.com
Contact Person: Norah Trent
Email: Send Email
Phone: +1 646 845 9349, +44 208 133 9349
City: Pune
State: Maharashtra
Country: India
Website: www.wiseguyreports.com